Related Experiment Video
Updated: Mar 16, 2026
11:13
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
9.3K
Idiopathic Fatal Pancytopenia: A Case Report
1Junior Resident, Department of Pathology, IMS, BHU , Varanasi, India .
Journal of Clinical and Diagnostic Research : JCDR
|August 10, 2016
Summary
Idiopathic Fatal Pancytopenia (IFP) is a newly identified, rapidly fatal condition characterized by unexplained pancytopenia. This case highlights the grave prognosis and need for medical community awareness.
Area of Science:
- Hematology
- Internal Medicine
- Pathology
Background:
- Pancytopenia, a decrease in red blood cells, white blood cells, and platelets, can result from various bone marrow diseases.
- Understanding the etiology of pancytopenia is crucial for patient management and prognosis.
Observation:
- A 55-year-old male presented with generalized weakness and melena.
- Initial investigations including CBC, stool occult blood test, abdominal imaging, and malignancy screening were inconclusive.
- Bone marrow examination, including smears, clot sections, biopsy, immunohistochemistry, and cytogenetics, revealed no abnormalities.
Findings:
- Despite extensive evaluation, the cause of pancytopenia remained unexplained.
- The patient's condition rapidly deteriorated, leading to the designation of Idiopathic Fatal Pancytopenia (IFP).
Implications:
- Idiopathic Fatal Pancytopenia (IFP) represents an emerging clinical entity with a poor prognosis.
- Increased awareness among clinicians and researchers is vital for recognizing and potentially managing this condition.